Choi Tae-Young, Kim Jong In, Lim Hyun-Ja, Lee Myeong Soo
1 Clinical Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
2 Division of Acupuncture & Moxibustion Medicine, Kyung Hee Korean Medicine Hospital, Kyung Hee University, Seoul, Republic of Korea.
Integr Cancer Ther. 2017 Jun;16(2):135-146. doi: 10.1177/1534735416664172. Epub 2016 Aug 16.
Insomnia is a prominent complaint of cancer patients that can significantly affect their quality of life and symptoms related to sleep quality. Conventional drug approaches have a low rate of success in alleviating those suffering insomnia. The aim of this systematic review was to assess the efficacy of acupuncture in the management of cancer-related insomnia.
A total of 12 databases were searched from their inception through January 2016 without language restriction. Randomized controlled trials (RCTs) and quasi-RCTs were included if acupuncture was used as the sole intervention or as an adjunct to another standard treatment for any cancer-related insomnia. The data extraction and the risk of bias assessments were performed by 2 independent reviewers.
Of the 90 studies screened, 6 RCTs were included. The risk of bias was generally unclear or low. Three RCTs showed equivalent effects on the Pittsburgh Sleep Quality Index and 2 RCTs showed the similar effects on response rate to those of conventional drugs at the end of treatment. The other RCT showed acupuncture was better than hormone therapy in the numbers of hours slept each night and number of times woken up each night. The 3 weeks of follow-up in 2 RCTs showed superior effects of acupuncture compared with conventional drugs, and a meta-analysis showed significant effects of acupuncture. Two RCTs tested the effects of acupuncture on cancer-related insomnia compared with sham acupuncture. One RCT showed favourable effects, while the other trial failed to do so.
There is a low level of evidence that acupuncture may be superior to sham acupuncture, drugs or hormones therapy. However, the number of studies and effect size are small for clinical significance. Further clinical trials are warranted.
失眠是癌症患者的一个突出问题,会显著影响他们的生活质量以及与睡眠质量相关的症状。传统药物方法在缓解失眠患者痛苦方面成功率较低。本系统评价的目的是评估针刺治疗癌症相关失眠的疗效。
检索了从建库至2016年1月的12个数据库,无语言限制。如果针刺被用作唯一干预措施或作为任何癌症相关失眠的另一种标准治疗的辅助手段,则纳入随机对照试验(RCT)和半随机对照试验。数据提取和偏倚风险评估由2名独立 reviewers 进行。
在筛选的90项研究中,纳入了6项RCT。偏倚风险总体不明确或较低。3项RCT显示在匹兹堡睡眠质量指数上有等效效果,2项RCT显示在治疗结束时对缓解率的影响与传统药物相似。另一项RCT显示针刺在每晚睡眠时间和每晚醒来次数方面优于激素治疗。2项RCT的3周随访显示针刺效果优于传统药物,荟萃分析显示针刺有显著效果。2项RCT测试了针刺与假针刺相比对癌症相关失眠的影响。一项RCT显示有良好效果,而另一项试验未显示。
证据水平较低,表明针刺可能优于假针刺、药物或激素治疗。然而,研究数量和效应大小较小,缺乏临床意义。需要进一步的临床试验。